Nerve block for postural tachycardia syndrome
Part of Brain & nervous system clinical trials.
This study looks at a treatment called a stellate ganglion block, which is an injection near a nerve in the neck that may help with symptoms of postural tachycardia syndrome (POTS), a condition that causes dizziness and a fast heartbeat when standing up. It also involves detailed health assessments to better understand POTS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a confirmed diagnosis of POTS from a cardiologist or neurologist within the last 3 years.
- You still have symptoms of orthostatic intolerance (like dizziness or fainting when standing) even if you are taking medication.
- You are not pregnant or breastfeeding.
- You do not have other serious health conditions like diabetes, heart failure, or kidney or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how physical activity affects symptoms in people with POTS (a condition where heart rate rises when standing). If you have POTS, you may be asked to participate and help the researchers understand whether exercise changes how you feel.
This study tests a nerve block in the neck to see if it can help reduce symptoms of postural tachycardia syndrome (POTS), a condition that causes dizziness and a fast heartbeat when standing up. The treatment aims to calm the nerves that may be overactive in POTS.
This trial studies whether an autoimmune (immune system–related) process is involved in postural tachycardia syndrome (POTS), a condition where your heart rate rises when you stand. The study may help researchers understand what causes POTS and how it could be treated or monitored.
This study looks at how the body controls heart rate and blood flow in people with POTS (a condition that causes dizziness and a fast heart rate upon standing). It helps researchers understand POTS better by comparing patients with healthy volunteers.
This study tests whether a daily pill called mirabegron can help control the rapid heartbeat and other symptoms of postural orthostatic tachycardia syndrome (POTS). If you join, you'll take the study drug or a placebo for a set time and track your symptoms.
This trial tests whether pyridostigmine helps people with postural tachycardia syndrome (POTS), which causes heart rate to rise when you stand up and can lead to unpleasant symptoms. You would be screened based on your tilt-table heart-rate response and your standing-related symptoms.
Hear when a new POTS - Postural Orthostatic Tachycardia Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.